Literature DB >> 10996223

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.

F H Yi1, C Lautrette, C Vermot-Desroches, D Bordessoule, P Couratier, J Wijdenes, J L Preud'homme, M O Jauberteau.   

Abstract

Sera from 26% of patients with sporadic amyotrophic lateral sclerosis (ALS) induced in vitro apoptosis of a human neuroblastoma cell line, as detected by two methods, and most contained anti-Fas autoantibodies. In contrast, Alzheimer sera (studied as controls) very rarely induced apoptosis and did not contain detectable anti-Fas antibodies. Soluble Fas-ligand levels in ALS sera were not different from those in normal sera, except for slightly higher levels in a single case. In mixed cultures of rat embryonic brain and spinal cord cells, ALS sera (and agonistic anti-Fas monoclonal antibodies and soluble Fas-ligand) induced the apoptosis of a subpopulation of neurons. These neurons were motoneurons on the basis of staining with the monoclonal antibody SMI 32 and Fas expression was restricted to these SMI 32-positive neurons. These data are compatible with the hypothesis of the participation of an autoimmune mechanism possibly related to anti-Fas autoantibodies in certain ALS patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996223     DOI: 10.1016/s0165-5728(00)00288-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  18 in total

Review 1.  Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.

Authors:  Deepti Lall; Robert H Baloh
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

2.  Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.

Authors:  Carsten W Lederer; Antonietta Torrisi; Maria Pantelidou; Niovi Santama; Sebastiano Cavallaro
Journal:  BMC Genomics       Date:  2007-01-23       Impact factor: 3.969

3.  Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis.

Authors:  Srikanth Ranganathan; Robert Bowser
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

4.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

Authors:  C Raoul; E Buhler; C Sadeghi; A Jacquier; P Aebischer; B Pettmann; C E Henderson; G Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

5.  Detection, epitope-mapping and function of anti-Fas autoantibody in patients with silicosis.

Authors:  Akiko Takata-Tomokuni; Ayako Ueki; Mieko Shiwa; Yumika Isozaki; Tamayo Hatayama; Hironobu Katsuyama; Fuminori Hyodoh; Wataru Fujimoto; Hiroaki Ueki; Masayasu Kusaka; Hisashi Arikuni; Takemi Otsuki
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

6.  Protective effect of memantine against Doxorubicin toxicity in primary neuronal cell cultures: influence a development stage.

Authors:  D Jantas; W Lason
Journal:  Neurotox Res       Date:  2009-02-04       Impact factor: 3.911

7.  Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.

Authors:  Melissa M Haulcomb; Nichole A Mesnard; Richard J Batka; Thomas D Alexander; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2014-07-01       Impact factor: 3.215

8.  Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis.

Authors:  Joanna Iłżecka
Journal:  Neurol Sci       Date:  2011-11-03       Impact factor: 3.307

9.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

10.  Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells.

Authors:  Meital Edri-Brami; Benyamin Rosental; Dana Hayoun; Michael Welt; Hila Rosen; Itzhak Wirguin; Beatrice Nefussy; Vivian E Drory; Angel Porgador; Rachel G Lichtenstein
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.